OBINUTUZUMAB

obinutuzumab 1 g/40 mL injection, 40 mL vial

OBINUTUZUMAB (15265K)

obinutuzumab 1 g/40 mL injection, 40 mL vial
15265K
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 18082)

Indication: Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Treatment phase: Pre-treatment prior to initiation of glofitamab
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 1000 mg # of repeats: 0 DPMA: $4,390.47 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gazyva
(obinutuzumab 1 g/40 mL injection, 40 mL vial)